U.S. Specialty Stores Stock News

NasdaqGS:CORZ
NasdaqGS:CORZSoftware

Core Scientific (CORZ) Valuation Check As AI Infrastructure Pivot And Texas Expansion Drive Investor Optimism

Core Scientific (CORZ) is back in focus after a series of events underscored its shift from crypto mining toward AI infrastructure, including new long-term hosting contracts, expanded power capacity, and a large Texas facility. See our latest analysis for Core Scientific. Those AI focused contracts and power expansions sit alongside sharp share price momentum. The stock’s 30 day share price return of 37.11% and year to date share price return of 80.93% have contributed to a 1 year total...
NasdaqGS:ARM
NasdaqGS:ARMSemiconductor

FTC Probe Puts Arm Licensing Model And Lofty Valuation In Focus

The U.S. Federal Trade Commission has reportedly opened an investigation into Arm Holdings' semiconductor licensing practices. Regulators are said to be examining whether NasdaqGS:ARM uses its position in chip architectures to impose restrictive terms on customers. The review focuses on the company’s core licensing and royalty model, which underpins relationships with major chipmakers such as Nvidia and Qualcomm. Arm designs chip architectures used across smartphones, data centers,...
NYSE:KKR
NYSE:KKRCapital Markets

Is KKR (KKR) Now A Long Term Opportunity After Recent Share Price Weakness

If you are wondering whether KKR at around US$90.53 is priced for opportunity or risk, the starting point is to understand what the current share price implies about its underlying value. The stock has had a mixed run, with the share price down about 4.7% over the past week, down 12.4% over the past month, down 29.8% year to date and down 24.4% over the last year, while still showing a 69.0% gain over three years and 70.8% over five years. Recent coverage has focused on KKR's role as a large...
NasdaqGS:DLTR
NasdaqGS:DLTRConsumer Retailing

Dollar Tree (DLTR) Is Up 17.3% After Strong Q1, New Stores And Buyback Completion – Has The Bull Case Changed?

In late May 2026, Dollar Tree reported first-quarter 2026 results with revenue of US$4,975.8 million and net income of US$347.3 million, alongside updated guidance, plans for approximately 400 new store openings and about 75 closures this fiscal year, and completion of a long-running US$6.25 billion share repurchase program. The company also expanded its reach by enabling on-demand delivery from more than 9,000 U.S. stores via DoorDash, offering over 10,000 products for convenient,...
NYSE:SF
NYSE:SFCapital Markets

Is Stifel Financial (SF) Offering Value After Recent Pullback And Capital Markets Headlines

Wondering if Stifel Financial, at a recent US$69.37 share price, is offering value or just noise? This article breaks down what that price could mean for you. The stock is down 1.8% over the past week and 9.2% over the past month, even though the 1 year return sits at 13.4% and the 3 year and 5 year returns are 83.9% and 76.5% respectively. Recent headlines around capital markets activity and the broader financial sector have kept investor attention on firms such as Stifel Financial. This...
NasdaqGS:NBIS
NasdaqGS:NBISSoftware

Nebius Group Repositions In AI Cloud After Nvidia Backing And Acquisitions

Nvidia CEO Jensen Huang publicly praised Nebius Group and announced a $2b investment partnership at Computex 2026. Nebius Group completed three AI focused acquisitions in Q1 2026, buying Tavily, Eigen AI, and Clarifai. The moves target inference optimization and agentic search, aiming to deepen Nebius Group’s AI cloud capabilities. Nebius Group (NasdaqGS:NBIS) is drawing fresh attention after securing both capital and public backing from Nvidia, a major force in AI infrastructure. The stock...
NasdaqGM:VCYT
NasdaqGM:VCYTBiotechs

Veracyte (VCYT) Is Up 9.4% After New Phase III Data Validates Prosigna Chemotherapy-Guidance Role – Has The Bull Case Changed?

Veracyte has recently reported strong Phase III clinical data for its Prosigna Breast and Decipher Prostate genomic tests at ASCO 2026 and confirmed the upcoming U.S. commercial launch of Prosigna on June 8, 2026 for early-stage hormone-receptor positive breast cancer patients. The new evidence suggests these tests can help oncologists tailor chemotherapy use more precisely, potentially sparing many high-risk breast and prostate cancer patients from unnecessary treatment and its long-term...
NYSE:RTX
NYSE:RTXAerospace & Defense

Is RTX (RTX) Still Fairly Priced After Recent Share Price Pullback?

If you are wondering whether RTX at around US$172.55 a share offers fair value or is starting to look stretched, the valuation picture is the key place to focus. RTX's share price has pulled back slightly in the short term, declining 2.3% over the last week and 0.2% over the last month, and is also down 7.9% year to date, even though it is still up 26.5% over 1 year, 86.5% over 3 years and 116.8% over 5 years. These mixed returns arrive as investors continue to weigh broader defense and...
NYSE:YUM
NYSE:YUMHospitality

Will Yum! Brands’ (YUM) COO Transition and New Roles Redefine Its Culture and Franchise Strategy?

Yum! Brands has announced that longtime Chief Operating Officer and Chief People & Culture Officer Tracy Skeans will retire, with her transitioning from her current roles on November 1, 2026, into a Senior Advisor position until March 1, 2028. Her planned retirement marks the departure of a key architect of Yum!’s franchising model and culture, prompting a multi‑year leadership transition as the company recruits a new Chief People & Culture Officer and a new Chief Scale Officer. With this...
NasdaqGS:CTAS
NasdaqGS:CTASCommercial Services

Assessing Cintas (CTAS) Valuation As Recent Momentum Softens And Narrative Fair Value Signals Upside

Recent performance snapshot Cintas (CTAS) has traded with mixed momentum recently, with the stock edging up about 0.8% on the day and roughly 4.7% over the past month, but declining around 14.6% over the past 3 months. See our latest analysis for Cintas. Looking beyond the latest move, Cintas has seen its short term share price momentum fade compared with earlier periods, even though the 3 year and 5 year total shareholder returns of 50.43% and 110.46% remain positive. If this kind of longer...
NYSE:S
NYSE:SSoftware

Why SentinelOne (S) Is Down 9.2% After Job Cuts Paired With Reaffirmed Revenue Guidance And What's Next

In late May 2026, SentinelOne reported first-quarter fiscal 2027 results showing sales of US$276.66 million and a reduced net loss of US$76.16 million, while reaffirming full-year revenue guidance and outlining expectations of US$289 million to US$291 million in second-quarter 2027 revenue and US$1.20 billion in revenue for the year ending January 31, 2027. The company also announced an 8% workforce reduction alongside continued investment in its AI-powered Singularity security platform,...
NYSE:ORCL
NYSE:ORCLSoftware

Is Oracle’s (ORCL) AI Spending Strategy Strengthening Its Moat or Stretching Its Balance Sheet?

In recent days, Oracle has come under pressure as investors weighed its heavy AI-related capital spending, bearish options positioning ahead of the June 10 earnings release, and broader weakness across software stocks. The news highlights how Oracle’s ambitious role in funding and operating AI infrastructure, once a key source of enthusiasm, is now raising pointed questions about free cash flow, balance-sheet risk, and the pace of converting its large AI contract backlog into realized...
NYSE:NUVB
NYSE:NUVBPharmaceuticals

A Look At Nuvation Bio (NUVB) Valuation After New IBTROZI Outcomes And Regulatory Progress

Nuvation Bio (NUVB) is back in focus after reporting new patient-reported outcomes from its pivotal TRUST-II study of IBTROZI in advanced ROS1+ non small cell lung cancer, alongside fresh regulatory milestones. See our latest analysis for Nuvation Bio. The recent TRUST-II data and regulatory updates arrive after a mixed share price pattern, with a 30 day share price return of 7.03% and a year to date share price decline of 44.99%, while the 1 year total shareholder return is 92.65% and the 3...
NasdaqGS:CTSH
NasdaqGS:CTSHIT

Cognizant Deepens AI And Security Ties As Valuation Lags Targets

Cognizant Technology Solutions (NasdaqGS:CTSH) expanded its AI collaboration with Snowflake to deploy AI-powered intelligent agents at scale across industries. The companies aim to help enterprises adopt AI more quickly, with a focus on AI-driven business workflows and measurable operational outcomes. Cognizant also broadened its alliance with CrowdStrike to address security and governance needs tied to large-scale AI deployments. Cognizant sits at the intersection of IT services, cloud...
NasdaqCM:LPTH
NasdaqCM:LPTHElectronic

LightPath Raises US$50m Equity For Growth While Dilution Weighs On Holders

LightPath Technologies (NasdaqCM:LPTH) has completed a follow-on equity offering via a registered direct deal. The company raised gross proceeds of US$50 million. Management plans to use the new capital for working capital, investments, acquisitions, and other corporate purposes. LightPath Technologies focuses on photonics solutions, supplying optical components and related products into areas where demand for high precision optics has been growing across multiple applications. This fresh...
NasdaqGS:XP
NasdaqGS:XPCapital Markets

Is XP (XP) Looking Attractive After Recent Share Price Pullback?

If you are wondering whether XP at around US$15.60 is starting to look like a bargain or still carries too much risk, the recent share performance gives you some important clues. The stock has fallen about 9% over the past week, around 15.7% over the past month, and is down 19.5% over the past year. This may change how investors think about both its potential and its risks. Recent coverage of XP has focused on how the stock has pulled back over different timeframes and what that says about...
NasdaqGS:DASH
NasdaqGS:DASHHospitality

Assessing DoorDash (DASH) Valuation After A Sharp Pullback And Diverging Fair Value Estimates

DoorDash stock performance snapshot DoorDash (DASH) has been under pressure recently, with the stock down about 10% over the past month and roughly 16% over the past 3 months, while the year to date decline is close to 30%. See our latest analysis for DoorDash. At a share price of US$154.58, DoorDash’s recent pullback, including a year to date share price decline of about 30%, contrasts with its much stronger 3 year total shareholder return of around 120%. This signals fading short term...
NYSE:ATHM
NYSE:ATHMInteractive Media and Services

A Look At Autohome (NYSE:ATHM) Valuation After First Quarter Revenue Drop And Operating Loss

Autohome (ATHM) recently reported first quarter results showing revenue and earnings pressure, including an operating loss, as China’s auto market contracted sharply and both automaker advertising and dealer activity on its platforms weakened. See our latest analysis for Autohome. The stock has fallen about 20% on a 1-year total shareholder return basis, while the year to date share price return is down nearly 20%. This suggests momentum has been fading despite recent dividend affirmation and...
NasdaqGS:ROP
NasdaqGS:ROPSoftware

How Roper’s Bigger Buyback and Dividend Hike Will Impact Roper Technologies (ROP) Investors

Roper Technologies recently announced a US$0.91 per-share dividend payable on 22 July 2026 to shareholders of record on 8 July 2026, while also expanding its share repurchase authorization by US$3.00 billion to leave US$3.80 billion in remaining capacity and raising its full-year earnings outlook following strong first-quarter results tied to AI-driven software demand. This combination of higher planned cash returns and an upgraded earnings outlook underlines management’s confidence in the...
NasdaqGM:BLBD
NasdaqGM:BLBDMachinery

Is It Too Late To Consider Blue Bird (BLBD) After Its 85% One Year Surge?

Some investors may be wondering whether Blue Bird's share price still offers value after a strong run, or if most of the opportunity has already been priced in. The stock last closed at US$72.43, with returns of 2.2% over 7 days, 15.2% over 30 days, 54.9% year to date and 85.6% over the past year. Recent coverage has focused on how this long term share price performance has sharpened the market's focus on what Blue Bird might be worth compared with its current price. Investors are watching...
NYSE:SO
NYSE:SOElectric Utilities

Southern Highlights Grid Upgrades As New Corporate Affairs Leader Steps In

Georgia Power, a subsidiary of Southern Company (NYSE:SO), appointed Anthony Oni as vice president of Corporate Affairs. The company also highlighted significant investments in grid upgrades as the Atlantic hurricane season begins. The announcement links a leadership change with operational preparations for severe weather events affecting Georgia Power's service territory. Southern, through Georgia Power, operates in a sector where reliability and storm readiness are core to the business...
NasdaqGS:CNXC
NasdaqGS:CNXCProfessional Services

Does Concentrix (CNXC) Becoming an AI CX Partner Reshape Its Long‑Term Competitive Narrative?

In recent days, Concentrix has been recognized on the Fortune 500 list for the third consecutive year, advanced its AI-powered iX and agentic platforms, and reported revenue and profitability in line with guidance while continuing to manage debt and invest in growth. Together, these developments highlight how Concentrix is positioning itself as an AI-focused customer experience partner at a time when enterprises are rethinking how people, technology, and automation work together. Next, we’ll...
NasdaqGS:ABNB
NasdaqGS:ABNBHospitality

Is It Time To Reassess Airbnb (ABNB) After Its Post Pandemic Share Price Surge

Many investors are asking whether Airbnb's current share price still makes sense after its post‑pandemic surge, or if the stock has drifted away from underlying value. At a last close of US$133.59, Airbnb has returned 1.1% over the past week, is down 3.8% over the past month, and has returned 0.4% year to date and 0.1% over the last year, with a 14.6% gain over three years but a 7.8% decline over five years. These figures may shape how you view both risk and opportunity. Recent headlines...
NYSE:TDOC
NYSE:TDOCHealthcare Services

Teladoc Health (TDOC) Is Up 7.6% After Walmart Expands $89 Virtual Care Visits Integration – Has The Bull Case Changed?

In May 2026, Walmart Inc. announced that Teladoc Health’s virtual urgent care, dermatology, and nutrition services are now available on Walmart’s Better Care Services platform for US$89 per cash-pay visit, with prescriptions eligible for same-day or free Walmart+ delivery in many locations. This expansion, building on the earlier integration of BetterHelp mental health services, plugs Teladoc deeper into Walmart’s extensive retail health ecosystem and broadens access to insured and cash-pay...